AN2 Therapeutics Inc
ANTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$209.82M
Close$
$0.66
85.5% downside
Current Fair Value
85.5% downsideOvervalued by 85.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $209.82 Million |
|---|---|
| Enterprise Value | $189.61 Million |
| Earnings per Share | $-1.16 |
| Beta | -0.94 |
| Outstanding Shares | 46,114,047 |
Return
| Return on Equity | -46.19% |
|---|---|
| Return on Assets | -42.56% |
| Return on Invested Capital | -48.74% |
Valuation & Multiples
| P/E Ratio | -4.89 |
|---|---|
| PEG | 32.78 |
| Price to Sales | - |
| Price to Book Ratio | 4.55 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.14 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 9, 2026
EPS
-$0.17
Est. -$0.20Revenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
-$0.22
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.45%▼ 52.61% |
|---|---|
| Total Invested | $5.85M▼ 95.10% |
| Investors Holding | 12▼ 55.00% |